Belagenpneumatucel-L is an anti-TGF-β allogeneic tumor cell vaccine, based on non-small cell lung cancer cells genetically engineered to express ASO directed against TGF-β [331,332,333]. Here, TGFB1 is linked to non-small cell lung carcinoma.